Dr. Louis-Philippe Bernier is a research associate at the University of British Columbia, in Vancouver BC, previously having completed his PhD at McGill University. Dr. Bernier has been studying the mechanisms of cerebrovascular control for 10 years, focusing on how neuroinflammation affects blood flow in the brain. Along with colleagues at the Vancouver General Hospital, he is now exploring the possibility that UDP-sugars, elevated in inflammatory conditions present following aSAH, contribute to the vasoconstriction often observed triggering vasospasms. The molecular mechanisms underlying post-aSAH vasospasm remain unknown, and they hope their studies will reveal pathways that can be targeted therapeutically.